Proton pump inhibitors and the risk of acquiring a penicillin allergy label.


Journal

Internal medicine journal
ISSN: 1445-5994
Titre abrégé: Intern Med J
Pays: Australia
ID NLM: 101092952

Informations de publication

Date de publication:
08 2023
Historique:
received: 26 01 2023
accepted: 04 05 2023
pmc-release: 07 08 2024
medline: 22 8 2023
pubmed: 7 8 2023
entrez: 7 8 2023
Statut: ppublish

Résumé

The negative consequences of having a penicillin allergy label are well established. Penicillin allergy de-labelling improves healthcare outcomes; however, less attention is paid to modifying risk factors leading to penicillin allergy development. In this propensity score-matched retrospective cohort study, we used a de-identified population-based database (TriNetX Research Network) and examined the 30-day risk of acquiring a penicillin allergy label in patients using proton pump inhibitors (PPIs). We demonstrated a higher risk of acquiring a penicillin allergy label among PPI users compared to controls.

Identifiants

pubmed: 37548300
doi: 10.1111/imj.16197
pmc: PMC10529584
mid: NIHMS1917333
doi:

Substances chimiques

Proton Pump Inhibitors 0
Penicillins 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

1481-1484

Subventions

Organisme : NCATS NIH HHS
ID : UL1 TR002014
Pays : United States
Organisme : NIH HHS
ID : UL1 TR002014
Pays : United States

Informations de copyright

© 2023 The Authors. Internal Medicine Journal published by John Wiley & Sons Australia, Ltd on behalf of Royal Australasian College of Physicians.

Références

Front Immunol. 2018 Jul 17;9:1584
pubmed: 30065721
Pediatr Allergy Immunol. 2013 Sep;24(6):582-8
pubmed: 23905907
FASEB J. 2005 Apr;19(6):656-8
pubmed: 15671152
Ann Allergy Asthma Immunol. 2010 Oct;105(4):259-273
pubmed: 20934625
J Allergy Clin Immunol. 2022 Dec;150(6):1333-1393
pubmed: 36122788
Clin Exp Allergy. 2013 Mar;43(3):344-52
pubmed: 23414543
World J Gastroenterol. 2019 Jun 14;25(22):2706-2719
pubmed: 31235994
Arch Intern Med. 2000 Oct 9;160(18):2819-22
pubmed: 11025792
Clin Exp Allergy. 2010 Mar;40(3):486-93
pubmed: 19817752
Perm J. 2004 Summer;8(3):20-4
pubmed: 26705167

Auteurs

Sarah Al-Obaydi (S)

Department of Medicine, Penn State College of Medicine, Pennsylvania State University, Hershey, Pennsylvania, USA.

Catherine A Popadiuk (CA)

Division of Pulmonary, Allergy & Critical Care, Department of Medicine, Penn State College of Medicine, Pennsylvania State University, Hershey, Pennsylvania, USA.

Taha Al-Shaikhly (T)

Division of Pulmonary, Allergy & Critical Care, Department of Medicine, Penn State College of Medicine, Pennsylvania State University, Hershey, Pennsylvania, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH